Mega Lifesciences PCL (BKK:MEGA)
Thailand flag Thailand · Delayed Price · Currency is THB
34.00
0.00 (0.00%)
At close: Dec 4, 2025

Mega Lifesciences PCL Balance Sheet

Millions THB. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Cash & Equivalents
3,4233,4632,3572,4532,1981,006
Upgrade
Short-Term Investments
349.85395.19365.05345.55342.64225.85
Upgrade
Cash & Short-Term Investments
3,7733,8582,7222,7992,5401,232
Upgrade
Cash Growth
29.42%41.74%-2.76%10.18%106.14%-16.02%
Upgrade
Accounts Receivable
3,1082,9753,3143,1072,5572,507
Upgrade
Other Receivables
303.93152.53158.28180.15164.1874.68
Upgrade
Receivables
3,4123,1283,4723,2872,7212,581
Upgrade
Inventory
3,1033,0333,3774,1093,8233,489
Upgrade
Prepaid Expenses
-60.4358.5960.1453.4343.95
Upgrade
Other Current Assets
155.08147.7360.23334.95162.8240.19
Upgrade
Total Current Assets
10,44310,2279,99010,5909,3017,587
Upgrade
Property, Plant & Equipment
2,3712,2132,2252,1512,1032,214
Upgrade
Long-Term Investments
38.1740.39221.15222.88214.79194.47
Upgrade
Goodwill
432.21449456.24465.88476.25437.32
Upgrade
Other Intangible Assets
864.91869.72862.23863.31876.89875
Upgrade
Long-Term Deferred Tax Assets
357.66299.89278.95250.32210.41175.03
Upgrade
Other Long-Term Assets
139.12111.5281103.4989.7574.27
Upgrade
Total Assets
14,64614,21014,11514,64613,27211,557
Upgrade
Accounts Payable
1,8091,6851,9252,7932,5272,048
Upgrade
Accrued Expenses
800.351,1021,1401,6041,283823.52
Upgrade
Short-Term Debt
437.61287.5876229.18168.18499.49
Upgrade
Current Portion of Leases
57.5363.8343.7882.9656.2136.67
Upgrade
Current Income Taxes Payable
178.83145.54108.45204.18185.86160.73
Upgrade
Other Current Liabilities
1,256630.651,133624.44633.02660.61
Upgrade
Total Current Liabilities
4,5403,9144,4275,5384,8534,229
Upgrade
Long-Term Leases
121.87139.83132.06108.73131.94111.31
Upgrade
Pension & Post-Retirement Benefits
300.94278.11251.91222.94261.28236.5
Upgrade
Long-Term Deferred Tax Liabilities
-1.052.14--0.98
Upgrade
Other Long-Term Liabilities
-----0.33
Upgrade
Total Liabilities
4,9634,3334,8135,8705,2474,578
Upgrade
Common Stock
435.94435.94435.94435.94435.94435.94
Upgrade
Additional Paid-In Capital
2,3052,3052,3052,3052,3052,305
Upgrade
Retained Earnings
7,7707,8307,2106,6555,7664,752
Upgrade
Comprehensive Income & Other
-826.62-693.31-648.11-618.9-503.97-534.41
Upgrade
Total Common Equity
9,6839,8779,3028,7778,0036,958
Upgrade
Minority Interest
0.110.080.020.0722.321.29
Upgrade
Shareholders' Equity
9,6839,8779,3028,7778,0256,979
Upgrade
Total Liabilities & Equity
14,64614,21014,11514,64613,27211,557
Upgrade
Total Debt
617.01491.24251.84420.87356.33647.47
Upgrade
Net Cash (Debt)
3,1563,3672,4702,3782,184584.84
Upgrade
Net Cash Growth
24.38%36.31%3.86%8.89%273.44%1.37%
Upgrade
Net Cash Per Share
3.623.862.832.732.500.67
Upgrade
Filing Date Shares Outstanding
871.87871.87871.87871.87871.87871.87
Upgrade
Total Common Shares Outstanding
871.87871.87871.87871.87871.87871.87
Upgrade
Working Capital
5,9036,3125,5635,0524,4483,358
Upgrade
Book Value Per Share
11.1111.3310.6710.079.187.98
Upgrade
Tangible Book Value
8,3868,5587,9847,4476,6505,645
Upgrade
Tangible Book Value Per Share
9.629.829.168.547.636.47
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.